Vernon Sondak is a General Surgeon in Tampa, Florida. Dr. Sondak is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Neuroendocrine Tumor, Adult Soft Tissue Sarcoma, and Lymphadenectomy. Dr. Sondak is currently accepting new patients.

Rodabe Amaria is an Oncologist and a Hematologist in Houston, Texas. Dr. Amaria is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Metastatic Brain Tumor.

Amod Sarnaik is a General Surgeon and a Surgical Oncologist in Tampa, Florida. Dr. Sarnaik is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Neuroendocrine Tumor, Lymphofollicular Hyperplasia, and Lymphadenectomy. Dr. Sarnaik is currently accepting new patients.

Craig Slingluff is a Surgical Oncologist in Charlottesville, Virginia. Dr. Slingluff is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, Neuroendocrine Tumor, and Tissue Biopsy.

Jennifer Mcquade is an Oncologist in Houston, Texas. Dr. Mcquade has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Sinus Cancer, Teratocarcinosarcoma, and Olfactory Neuroblastoma.

Anthony Olszanski is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Olszanski is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.

Joseph Clark is a Hematologist Oncology specialist and a Hematologist in Maywood, Illinois. Dr. Clark is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Nasopharyngeal Carcinoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Clark is currently accepting new patients.

Eric Whitman is a General Surgeon and a Surgical Oncologist in Morristown, New Jersey. Dr. Whitman is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Pancreatic Cancer, Hyperparathyroidism, and Familial Pancreatic Cancer.

Sekwon Jang is a Hematologist Oncology specialist and an Oncologist in Falls Church, Virginia. Dr. Jang is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Cutaneous T-Cell Lymphoma (CTCL), and Squamous Cell Skin Carcinoma. Dr. Jang is currently accepting new patients.

Richard Carvajal is an Oncologist in Lake Success, New York. Dr. Carvajal is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy.

Giorgos Karakousis is a General Surgeon in Philadelphia, Pennsylvania. Dr. Karakousis is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Adult Soft Tissue Sarcoma, Lymphadenectomy, and Gastrectomy. Dr. Karakousis is currently accepting new patients.

Diwakar Davar is a Hematologist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Davar is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Uveal Melanoma, and Gamma Knife Radiosurgery.

Kim Margolin is an Oncologist in Santa Monica, California. Dr. Margolin is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Testicular Cancer, and Metastatic Brain Tumor. Dr. Margolin is currently accepting new patients.

Brian Gastman is a Plastic Surgeon in Cleveland, Ohio. Dr. Gastman is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Squamous Cell Skin Carcinoma, Tissue Biopsy, and Osteotomy.

Lynn Schuchter is an Oncologist in Philadelphia, Pennsylvania. Dr. Schuchter is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Melanoma of the Eye, Squamous Cell Skin Carcinoma, and Merkel Cell Carcinoma. Dr. Schuchter is currently accepting new patients.

Mark Faries is an Oncologist and a Surgical Oncologist in Los Angeles, California. Dr. Faries is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Squamous Cell Skin Carcinoma, and Lymphadenectomy. Dr. Faries is currently accepting new patients.

Brendan Curti is an Oncologist in Portland, Oregon. Dr. Curti is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Prostate Cancer, and Chromophobe Renal Cell Carcinoma.

John M. Kirkwood, MD, is a professor of medicine, dermatology, and clinical and translational science at the University of Pittsburgh School of Medicine and the Clinical and Translational Science Institute at the University of Pittsburgh. Dr. Kirkwood directs the Melanoma Center at UPMC Hillman Cancer Center and specializes in melanoma research and the prevention and early detection of melanoma, as well as the treatment of advanced disease and adjuvant therapy of resectable disease. Dr. Kirkwood is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Uveal Melanoma.

Mohammed Kashani is a Dermatologist in San Francisco, California. Dr. Kashani is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Mycosis Fungoides, Anaplastic Large Cell Lymphoma, and Lymphadenectomy. Dr. Kashani is currently accepting new patients.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Pancreaticoduodenectomy.